Making vascular access complications history

At the AVATAR group, we know that vascular access device insertion can be difficult and painful. After insertion, 25% to 50% fail due to infection, blockage, dislodgement or vessel damage. We conduct scientific work to improve hospital and homecare practices, test new products and promote global networks of vascular access researchers. We strive to eliminate ineffective practices and replace them with innovative solutions, providing patients with a better healthcare experience and saving healthcare providers millions of dollars.

Visit our website

Read more about our work

PUBLICATIONS

Read more about our research along with current and historical publications.

Read more

Co-lead

Professor Claire Rickard

Professor Rickard PhD is a registered nurse working to reduce complications for people receiving medical treatment through catheters in their veins and arteries.

Co-lead

Associate Professor Andrew Bulmer

Associate Professor Bulmer's research has two foci, the first of which includes revealing the importance of haem catabolism and bilirubin biology within inflammatory pathology, particularly atherosclerosis. Secondly, our group aims to reduce vasculitis and thrombotic events in patients enduring invasive vascular access devices/procedures with the AVATAR group.

MEMBERS AND CHAPTERS

The AVATAR Group comprises more than 100 experts in Australia and internationally.

Meet our team

PARTNERS

Partners play an important role in developing reliable, practical and cost-effective products for the delivery of medical treatment and improving patient care. We engage with partners in a number of different ways.

Read more

Sponsor our research

Donations help drive our world-class research